4//SEC Filing
Narula Sanjeev 4
Accession 0001193125-25-233684
CIK 0001783183other
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 5:25 PM ET
Size
5.5 KB
Accession
0001193125-25-233684
Insider Transaction Report
Form 4
Narula Sanjeev
Chief Financial & Bus. Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-10-06+200,000→ 200,000 totalExercise: $11.61Exp: 2036-10-05→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The stock option will vest with respect to 25% of the shares of common stock on October 6, 2026, and will vest with respect to the remaining shares in equal monthly installments over the following three years, subject to the Reporting Person's continuous service to the Issuer on the applicable vesting dates.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001820590
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 5:25 PM ET
- Size
- 5.5 KB